ReviewCureus2026

Efficacy and Safety of Human Epidermal Growth Factor Receptor 2 (HER2) Antibody-Drug Conjugates in Solid Tumors Harboring Non-tyrosine Kinase Domain ERBB2 Mutations: A Systematic Review.

Ryuichi Ohta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.